NCT00907504View on ClinicalTrials.gov

Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

CP-751,871

CP-751,871 20mg/kg every 3 weeks

DRUG

Cisplatin

Cisplatin 80 mg/m2 every 3 weeks

DRUG

Gemcitabine

Gemcitabine 1,250 mg/m2 Day1+8 of evey 3 week-cycle

DRUG

Cisplatin

Cisplatin 80 mg/m2 every 3 weeks

DRUG

Gemcitabine

Gemcitabine 1,250 mg/m2 Day1+8 of evey 3 week-cycle

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00907504 - Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter